Translational Research

Scope & Guideline

Bridging Lab Discoveries to Clinical Realities

Introduction

Welcome to the Translational Research information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Translational Research, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1931-5244
PublisherELSEVIER SCIENCE INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2006 to 2024
AbbreviationTRANSL RES / Transl. Res.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressSTE 800, 230 PARK AVE, NEW YORK, NY 10169

Aims and Scopes

The journal "Translational Research" focuses on bridging the gap between laboratory research and clinical practice, emphasizing the translation of scientific discoveries into effective therapeutic strategies. It covers a wide spectrum of medical disciplines, with a particular interest in innovative approaches to disease prevention, diagnosis, and treatment.
  1. Clinical Translational Research:
    The journal prioritizes research that translates basic scientific discoveries into clinical applications, enhancing patient care and therapeutic outcomes.
  2. Multi-disciplinary Approaches:
    It encourages studies that involve collaboration across various fields, including molecular biology, pharmacology, and clinical medicine, to address complex health issues.
  3. Innovative Therapeutics:
    Research on novel therapeutic strategies, including drug development, gene therapy, and regenerative medicine, is a core focus.
  4. Patient-Centric Studies:
    Emphasis is placed on studies that consider patient outcomes, quality of life, and personalized medicine approaches.
  5. Biomarker Discovery and Validation:
    The journal supports research aimed at identifying and validating biomarkers for disease diagnosis, prognosis, and treatment response.
  6. Health Systems and Policy Research:
    It also welcomes studies that explore the implications of research findings on healthcare systems, policies, and practices.
The journal "Translational Research" is currently witnessing a surge in specific themes that reflect the evolving landscape of medical research and clinical practice. These emerging scopes indicate a focus on innovative strategies and contemporary health challenges.
  1. Precision Medicine:
    There is a growing interest in research that tailors medical treatment to individual characteristics, such as genetics and lifestyle, enhancing the effectiveness of therapies.
  2. Artificial Intelligence and Machine Learning:
    Studies incorporating AI and machine learning for diagnostic and therapeutic purposes are increasingly prevalent, showcasing the integration of technology in healthcare.
  3. Regenerative Medicine:
    Research focusing on stem cell therapy, tissue engineering, and regenerative strategies is on the rise, reflecting advancements in treating degenerative diseases.
  4. Microbiome Research:
    The exploration of the human microbiome's role in health and disease is gaining traction, highlighting its potential impact on treatment modalities.
  5. Immunotherapy and Cancer Treatment:
    There is a marked increase in studies related to immunotherapy, particularly in cancer treatment, as researchers explore novel ways to harness the immune system.
  6. Telemedicine and Remote Monitoring:
    The COVID-19 pandemic has accelerated research in telemedicine and remote patient monitoring technologies, reflecting the need for accessible healthcare solutions.

Declining or Waning

While "Translational Research" continues to evolve, certain themes are becoming less prominent in recent publications. These waning areas suggest a shift in focus towards more pressing contemporary health issues and innovative methodologies.
  1. Traditional Clinical Trials:
    There is a noticeable decrease in the publication of traditional, single-center clinical trials, as the journal shifts towards more complex, multi-disciplinary, and translational studies.
  2. Basic Science Studies without Clinical Relevance:
    Research that does not have a clear application or relevance to clinical practice is becoming less common, reflecting a trend towards studies with direct patient impact.
  3. Generic Drug Research:
    Publications focusing solely on generic drugs or established therapies are waning, as the journal emphasizes novel therapeutic approaches and innovative drug development.
  4. Non-Translational Research:
    There is a decline in studies that do not bridge the gap between laboratory findings and clinical application, as the journal aims to prioritize translational outcomes.

Similar Journals

World of Medicine and Biology

Exploring the intersection of biology and health.
Publisher: SCIENTIFIC SOC ANATOMISTS HISTOLOGISTS & EMBRYOLOGISTS UKRAINEISSN: 2079-8334Frequency: 4 issues/year

World of Medicine and Biology is a leading academic journal dedicated to advancing the frontiers of medical and biological sciences. Published by the Scientific Society of Anatomists, Histologists & Embryologists in Ukraine, this journal provides a collaborative platform for researchers, professionals, and students to disseminate original research, critical reviews, and insightful discussions on a wide array of topics in these dynamic fields. With the ISSN 2079-8334, the journal aspires to bridge the gap between theory and practice, focusing on innovative methodologies, latest findings, and the relevance of biology to human health. Although the journal operates under a traditional access model, it ensures comprehensive reach through various indexing services and databases, solidifying its importance in the realm of scientific inquiry. As the field continues to evolve with new discoveries and technologies, the World of Medicine and Biology remains committed to fostering academic excellence and supporting the global research community in their endeavors.

Nature Reviews Clinical Oncology

Advancing the Frontiers of Cancer Care
Publisher: NATURE PORTFOLIOISSN: 1759-4774Frequency: 12 issues/year

Nature Reviews Clinical Oncology is a premier journal dedicated to the comprehensive exploration and critical evaluation of current advancements in the field of clinical oncology. Published by the esteemed NATURE PORTFOLIO in the United Kingdom, this influential journal boasts an impressive impact factor that reflects its significant role in shaping oncology research. As a Q1 ranked journal in Scopus, it occupies a notable position within the top tier of oncology publications, placing it in the 99th percentile among its peers. With a history of convergence from 2009 to 2024, it presents high-quality content through an open-access model, ensuring accessibility to vital research findings. Researchers, professionals, and students alike will find Nature Reviews Clinical Oncology an invaluable resource for staying abreast of the latest trends, biologic insights, and therapeutic innovations that drive the future of cancer treatment.

JOURNAL OF INVESTIGATIVE MEDICINE

Elevating Knowledge in Investigative Medicine
Publisher: SAGE PUBLICATIONS LTDISSN: 1081-5589Frequency: 8 issues/year

JOURNAL OF INVESTIGATIVE MEDICINE, published by SAGE PUBLICATIONS LTD, serves as a vital resource for researchers and professionals in the fields of biochemistry, genetics, and medicine. With an impressive Scopus ranking placing it in the 64th percentile, the journal consistently showcases significant research, fostering advancements in our understanding of complex biological processes. Spanning from 1994 to 2024, this quarterly publication is recognized as Q2 in both Biochemistry, Genetics and Molecular Biology and Medicine categories, indicating its relevance and quality in these disciplines. While the journal does not offer open access, it provides robust insights that assist in shaping current academic and clinical practices. Located in the United States, the JOURNAL OF INVESTIGATIVE MEDICINE is essential for scholars aiming to stay at the forefront of investigative medical research.

CLINICAL AND EXPERIMENTAL MEDICINE

Exploring New Frontiers in Biomedical Research
Publisher: SPRINGER-VERLAG ITALIA SRLISSN: 1591-8890Frequency: 4 issues/year

Clinical and Experimental Medicine is a leading journal published by Springer-Verlag Italia SRL, dedicated to advancing the understanding of the intricate relationships between biomedical research and clinical applications. Since its inception in 2001, the journal has garnered an esteemed reputation, achieving Q1 quartile rankings in 2023 in both Biochemistry, Genetics and Molecular Biology (miscellaneous) and Medicine (miscellaneous), establishing itself as a key resource for researchers and practitioners alike. With an impactful contribution reflected in its Scopus rankings, particularly a #81/221 rank in the General Biochemistry, Genetics and Molecular Biology category, Clinical and Experimental Medicine serves as a rich platform for peer-reviewed articles that bridge theory and practice across diverse medical disciplines. The journal embraces Open Access options, broadening the accessibility of groundbreaking research to a global audience, thereby fostering collaboration and innovation. Located in Milan, Italy, it continually endeavors to enrich knowledge and share valuable insights essential for the advancement of health sciences.

Advances in Medical Sciences

Fostering excellence in medical research and practice.
Publisher: ELSEVIER URBAN & PARTNER SP Z O OISSN: 1896-1126Frequency: 2 issues/year

Advances in Medical Sciences is a peer-reviewed journal published by Elsevier Urban & Partner Sp. z o.o., dedicated to fostering advancements in the field of medicine and healthcare. Established in 2006, this esteemed journal has become a vital resource for researchers, professionals, and students alike, ranking in the Q2 category for Medicine (Miscellaneous) in 2023 and achieving an impressive 84th percentile in the Scopus rankings for General Medicine, placing it at 99 out of 636 journals. With a focus on publishing high-quality research and comprehensive reviews, this journal serves as a platform for disseminating innovative findings that push the boundaries of medical science. Although open access options are not currently available, the journal's rigorous standards ensure that every published article contributes significantly to the global medical community and promotes the understanding of contemporary medical challenges. Located in Wroclaw, Poland, the journal continues to engage a wide readership, driving forward the dialogue in various facets of medical research.

ANNALS OF CLINICAL AND LABORATORY SCIENCE

Elevating Standards in Medical Laboratory Technology
Publisher: ASSOC CLINICAL SCIENTISTSISSN: 0091-7370Frequency: 6 issues/year

ANNALS OF CLINICAL AND LABORATORY SCIENCE, published by the Association of Clinical Scientists, is a pivotal journal in the fields of clinical biochemistry, hematology, immunology, and medical laboratory technology. Since its inception in 1971, this journal has become a vital resource for researchers and practitioners aiming to advance their knowledge and skills in laboratory sciences. Although currently not an open access journal, its rich repository of peer-reviewed articles and studies contributes significantly to the academic discourse in diagnostic and therapeutic practices. The journal is categorized in various quartiles, reflecting its impact and contributions to multiple scientific domains, such as Q4 in Clinical Biochemistry and Q3 in Pathology and Forensic Medicine as of 2023. With an extensive convergence of years up to 2024, it proves to be a timeless source for emerging trends and research innovations. The ANNALS OF CLINICAL AND LABORATORY SCIENCE not only supports the professional development of its readers but also encourages interdisciplinary collaboration, making it an essential tool for professionals, students, and researchers dedicated to improving health outcomes through advanced laboratory sciences.

International Cardiovascular Research Journal

Transforming laboratory insights into clinical applications.
Publisher: SHIRAZ UNIV MEDICAL SCIENCES, CARDIOVASCULAR RESEARCH CENTERISSN: 2251-9130Frequency: 4 issues/year

International Cardiovascular Research Journal, published by Shiraz University Medical Sciences, serves as a vital platform for the dissemination of cutting-edge research in the field of cardiology and cardiovascular medicine. Since its inception in 2011, this journal has continuously devoted itself to promoting the highest quality of scholarly communication, helping to bridge the gap between laboratory findings and clinical application. With an ISSN of 2251-9130 and an E-ISSN of 2251-9149, it is indexed in prominent databases, contributing to its visibility and accessibility to a global audience. Although currently classified in the Q4 quartile in the 2023 rankings, the journal is committed to enhancing its impact factor and academic stature. It aims to facilitate open access for all published articles, although specific details on access options are pending. Through its rigorous peer-review process and diverse scope—which encapsulates advancements, clinical studies, and innovative therapeutic strategies—this journal fosters academic collaboration in the realm of cardiovascular health, making it an invaluable resource for researchers, practitioners, and students alike.

CURRENT MOLECULAR MEDICINE

Advancing the Frontiers of Molecular Medicine
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1566-5240Frequency: 10 issues/year

CURRENT MOLECULAR MEDICINE is a pivotal journal fostering advancements in the interdisciplinary fields of molecular medicine, biochemistry, and genetics. Published by Bentham Science Publishers, this esteemed journal has been disseminating vital research findings since its inception in 2001 and is continuously dedicated to exploring the molecular basis of health and disease. With a focus on translational research, CURRENT MOLECULAR MEDICINE provides an invaluable platform for researchers, healthcare professionals, and students, making significant contributions to the understanding of molecular mechanisms and therapeutic strategies. With an ISSN of 1566-5240 and an E-ISSN of 1875-5666, the journal holds a commendable position within the scientific community, being ranked Q3 in Biochemistry and Molecular Biology and Q2 in Medicine (miscellaneous) as of 2023. This journal does not currently operate on an open access model but remains accessible through various institutional subscriptions. The multidisciplinary scope covering molecular biology to medicinal applications positions CURRENT MOLECULAR MEDICINE as an essential resource for those striving to meet the challenges of modern healthcare and biomedical research.

Acta Facultatis Medicae Naissensis

Innovative Insights for a Healthier Tomorrow
Publisher: UNIV NIS, FAC MEDICINEISSN: 0351-6083Frequency: 4 issues/year

Acta Facultatis Medicae Naissensis is an esteemed open-access journal published by the University of Niš, Faculty of Medicine, situated in Serbia. Since its inception in 2009, this journal has been a vital platform for the dissemination of innovative research findings in the field of Medicine, particularly focusing on miscellaneous areas within the discipline. With an ISSN of 0351-6083 and an E-ISSN of 2217-2521, it operates under a commitment to free accessibility, enhancing visibility for authors and readers alike since 2012. In the 2023 categorization, it holds a respectable Q4 ranking in Medicine (Miscellaneous) and positions itself at the 34th percentile among general medicine publications in Scopus, reflecting its growing academic impact. Researchers, professionals, and students seeking an interactive scholarly exchange in medicine will find Acta Facultatis Medicae Naissensis a rich resource, contributing significantly to the understanding of health sciences and clinical practice through its diverse range of articles.

American Journal of Translational Research

Fostering Knowledge Exchange in Molecular Biology
Publisher: E-CENTURY PUBLISHING CORPISSN: 1943-8141Frequency: 12 issues/year

The American Journal of Translational Research is a pivotal publication in the fields of Biochemistry, Genetics, and Molecular Biology, dedicated to advancing the understanding of translational science and its applications in clinical settings. Published by E-CENTURY PUBLISHING CORP, this journal, under ISSN 1943-8141, fosters scholarly exchange by publishing original research articles, reviews, and clinical studies that bridge the gap between laboratory discoveries and actual medical practice. Although its coverage in Scopus has been discontinued, the journal has previously held respectable rankings, including a 64th percentile in Clinical Biochemistry and 52nd in both Molecular Medicine and Cancer Research, indicating its influence and relevance in the scientific community. With its formal objective of disseminating significant findings that inform clinical practices, the journal remains a valuable resource for researchers, healthcare professionals, and students eager to stay at the forefront of translational research advancements.